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Abstract
Aims and Background: ProteinO-linked glycosylation is regulated in vivo by
the concentration of hexosamine substrates. Calorie restriction (60% of ad
libitum intake) for 20 days causes decreased UDP-N-acetylhexosamine levels
and increased insulin-mediated glucose transport in rat skeletal muscle. Con-
versely, prolonged incubation (19 h) ofmuscle withO-(2-acetamido-2-deoxy-
d-glucopyranosylidene)amino-N-phenyl-carbamate (PUGNAc; an inhibitor
of N-acetyl-b-d-glucosaminidase) is characterized by increased O-linked gly-
cosylation and insulin resistance.We aimed to determine the calorie restriction
effect on O-linked glycosylation and characterize the temporal relationship
between PUGNAc-induced O-linked glycosylation and insulin resistance.
Hypothesis: A calorie restriction protocol characterized by decreased muscle
hexosamine levels will result in a global reduction in O-linked glycosylated
proteins in muscle, and PUGNAc-induced insulin resistance will coincide
with increased O-linked glycosylation.
Methods: Plantarismuscle and liver from rats (ad libitum or calorie restricted)
were analysed for O-linked glycosylation using two antibodies against dif-
ferent O-linked N-acetylglucosamine epitopes. Also, rat epitrochlearis mus-
cles were incubated for 8.5 h  100 lm PUGNAc prior to measurement of
[3H]-3-O-methylglucose transport and O-linked glycosylation.
Results: Calorie restriction did not alter protein O-linked glycosylated levels
in muscle or liver. Incubation with PUGNAc for 8.5 h resulted in increased
in O-linked glycosylation but unaltered basal or insulin-stimulated glucose
transport.
Conclusions: The delay between O-linked glycosylation and insulin resist-
ance in muscle incubated with PUGNAc suggests an indirect, relatively slow
mechanism for insulin resistance. The effect of calorie restriction on insulin
action in muscle is unlikely to be the direct result of a global change in
protein O-linked glycosylation.
Keywords diet restriction, food restriction, hexosamine, insulin resistance,
O-GlcNAcylation, PUGNAc.
The hexosamine biosynthetic pathway (HBP) and post-
translational modification of proteins via O-linkage of a
single N-acetylglucosamine to serine and threonine
residues (O-GlcNAcylation) have been likened to a
nutrient sensing mechanism and suggested to modulate
glucose metabolism (Wells et al. 2003). It has been
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estimated that a small fraction of the glucose (3–5%)
that enters cells is directed through the HBP (Marshall
et al. 1991). Fructose-6-phosphate and glutamine are
converted to glucosamine-6-phosphate by glutamine/
fructose-6-phosphate amidotransferase (GFAT), the
first- and rate-limiting step in the HBP. UDP-N-
acetylglucosamine (UDP-GlcNAc), an endproduct of
the HBP, serves as the substrate for O-glucosamine
transferase (OGT) in the O-linked glycosylation of
proteins on specific serine and threonine residues (Hart
1997). O-GlcNAcase is a nucleocytoplasmic enzyme
and the neutral glycosidase that cleaves O-GlcNAc
from the protein, a process that is analogous to the
dephosphorylation function of a phosphatase. Thus,
O-GlcNAcylation is a dynamic process of transfer and
removal of O-GlcNAc and has been detected in normal
and abnormal conditions.
Marshall et al. (1991) first described the relationship
between the HBP and insulin-stimulated glucose uptake
in cultured adipocytes. Subsequently, a number of
conditions which have increased flux through the
HBP, e.g. prolonged hyperglycemia (Rossetti et al.
1990), increasing plasma levels of glucosamine (Yki-
Järvinen et al. 1998), and transgenic mice overexpress-
ing GFAT (Hebert et al. 1996), have been demonstrated
to also be characterized by insulin resistance. Several
studies have provided evidence that alterations in
protein O-GlycNAcylation can influence insulin action.
Vosseller et al. (2002) reported that prolonged (19 h)
incubation of 3T3-L1 adipocytes in O-(2-acetamido-2-
deoxy-d-glucopyranosylidene)amino-N-phenyl-carbamate
(PUGNAc), a potent inhibitor of N-acetyl-b-d-glucosa-
minidase (O-GlcNAcase), induced extensive O-GlcNA-
cylation of proteins as well as insulin resistance for
glucose uptake. Recently, we reported similar findings in
rat epitrochlearis muscle: prolonged (19 h) incubation
in PUGNAc elicited increased O-GlcNAcylation of
multiple proteins identified using an antibody against
b-O-linked N-acetylglucosamine. Furthermore, PUG-
NAc also induced a decrease in glucose transport with a
physiologic insulin concentration (Arias et al. 2004).
In contrast to interventions which lead to insulin
resistance, calorie restriction (CR; consuming 60% of
ad libitum, AL, intake) by rats or mice can increase
insulin-stimulated glucose transport by skeletal muscle,
and this effect can occur with only 20 days of CR
(Cartee & Dean 1994, Dean & Cartee 1996, Dean
et al. 1998, Gazdag et al. 1998, 2000, Davidson et al.
2002, McCurdy et al. 2003). It would be important
to identify the molecular processes that trigger the
CR-induced increase in insulin sensitivity. Consistent
with the apparent inverse relationship between HBP
flux and insulin sensitivity, the CR-induced increase
in insulin-stimulated glucose transport is accompan-
ied by a reduction in skeletal muscle levels of
UDP-N-acetylhexosamines (acetylglucosamine and ace-
tylgalactosamine) (Gazdag et al. 2000).
O-GlcNAcylation appears to be predominantly
regulated by the cellular concentrations of UDP-
GlcNAc (Kreppel & Hart 1999). In light of the CR-
induced decline in UDP-GlcNAc levels in skeletal
muscle (Gazdag et al. 2000), in this study, our
principal aim was to assess possible differences
between calorie restricted and ad libitum rats in
protein O-GlcNAcylation of skeletal muscle. In addi-
tion, to gain more insights into the link between
protein O-GlcNAcylation and insulin action, we per-
formed further research using PUGNAc with isolated
skeletal muscle. Previous studies found that 19 h of
incubation in PUGNAc induced insulin resistance in
3T3-L1 adipocytes (Vosseller et al. 2002) and skeletal
muscle (Arias et al. 2004). It seemed valuable to
further examine the temporal relationship between
PUGNAc’s effects on protein O-GlcNAcylation and
insulin-stimulated glucose transport. Accordingly, we
assessed the effects of a shorter duration (8.5 h) of
PUGNAc exposure on incubated rat skeletal muscle
prior to measuring protein O-GlcNAcylation status
and glucose transport.
Methods
Materials
Unless otherwise noted, all chemicals were purchased
from Sigma Chemical (St Louis, MO, USA) or Fisher
Scientific (Hanover Park, IL, USA). Teklad Rodent
Diet no. 8604 was purchased from Harlan Teklad
(Madison, WI, USA). Dulbecco’s Modified Eagle’s
medium (DMEM; catalogue no. 31600) was purchased
from GIBCO Invitrogen (Grand Island, NY, USA).
O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-
N-phenyl-carbamate (PUGNAc) was purchased from
CarboGen Labs (Aarau, Switzerland). Human recom-
binant insulin (HumulinR) was purchased from Eli
Lilly (Indianapolis, IN, USA). [3H]-3-O-methylglucose
and [14C]-mannitol were purchased from NEN
(Downers Grove, IL, USA). Reagents and apparatus
for SDS-PAGE and immunoblotting were obtained from
Bio-Rad (Richmond, CA, USA). Anti-b-O-linked
N-acetylglucosamine (CTD110.6 clone; catalogue no.
MMS-248R) antibody was purchased from Covance
(Princeton, NJ, USA). Anti-O-linked N-acetylglucosa-
mine (RL2 clone; catalogue no. MA1-072) was pur-
chased from Affinity Bioreagents (Denver, CO, USA).
Reagents for the bicinchoninic acid (BCA) protein assay
were purchased from Pierce Biotechnology (Rockford,
IL, USA). Enhanced chemiluminescence (ECL) kits were
purchased from Amersham Pharmacia Biotechnology
(Piscataway, NJ, USA).
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Animal treatment
All animal procedures were approved by the Animal
Care and Use Committee of the University of Wis-
consin–Madison. We performed two experiments: for
Experiment 1, 4 month old, male Fischer 344 · Brown
Norway, F1 generation (F344BNF1/Nia) rats were
obtained from the National Institute on Aging from
Harlan Sprague Dawley (Indianapolis, IN, USA). For
these animals, a four-step diet protocol was used
(Davidson et al. 2002). Step 1: Upon arrival at the
animal facility, the rats were provided with chow and
water ad libitum for an 1-week acclimatization period.
Step 2: Subsequently, individual baseline food intake
was determined by allowing rats unlimited access to
food for 1 week and measuring food intake corrected
for spillage. Step 3: Animals were then familiarized to a
meal-feeding protocol for another week. The meal-
feeding protocol consisted of providing rat chow in
three 1.5-h periods over the course of each day. Step 4:
Following the familiarization period, the ad libitum
(AL) rats were given 100% of their individual baseline
intake for a period of 20 days, while the CR rats
received 60% of their individual intake for 20 days as
determined during the baseline period. Both groups
received the same per cent allotment accordingly (35%
at 06:00 h, 25% at 15:00 h, and 40% at 20:00 h).
For experiment 1, animals received their 06:00 h
meal on the experimental day, were transported from
the animal facility to the laboratory at 10:00 h and were
anaesthetized with an intraperitoneal injection of
sodium pentobarbital [5 mg (100 g))1 body wt]
between 12:00 h and 14:00 h. Upon loss of pedal
reflexes, plantaris muscles (fibre type composition: 15,
31, and 54%, for type I, type IIa, and type IIb,
respectively) (Holloszy et al. 1991) and liver were
quickly excised, freeze-clamped and stored at )80 C
until further processing.
Experiment 2 was performed to assess the effects of
in vitro incubation of skeletal muscle with O-(2-ace-
tamido-2-deoxy-d-glucopyranosylidene)amino-N-phenyl-
carbamate (PUGNAc), an inhibitor of the enzyme that
catalyses removal of O-GlcNAc modifications from
proteins. Male Wistar rats (1.5 month old) were
obtained from Harlan (Indianapolis, IN, USA) and
provided with Purina rat chow and water ad libitum.
Upon arrival at the animal facility, the animals were
acclimated to their surroundings for 2–3 days and
fasted at 18:00 h on the night prior to each experiment.
For experiment 2, on the day of muscle dissections
between 12:00 h and 14:00 h, the animals were anaes-
thetized with an intraperitoneal injection of sodium
pentobarbital [5 mg (100 g))1 body wt]. Upon loss of
pedal reflexes, epitrochlearis muscles (fibre type com-
position: 8, 17, and 75% for type I, type IIa, and type
IIb, respectively) (Wallberg-Henriksson 1987) were
quickly excised and transferred into the tissue incuba-
tion media.
Muscle incubation and glucose transport
The protocol used for epitrochlearis incubation is
similar to those previously described (Arias et al.
2004), but modified for 8.5 h rather than 19 h PUG-
NAc exposure. Briefly, following dissection, muscles
were incubated for 8 h in flasks containing 1.5 mL low
glucose (5.5 mm) DMEM supplemented to contain
2.54 mm CaCl2 and 25 mm NaHCO3. Flasks were
placed in a shaking water bath at 35 C and continu-
ously gassed with 95% O2/5% CO2 throughout the
experiment. After 4 h incubation, the media was
discarded and replaced with fresh DMEM supplemen-
ted as described above.
Following the 8 h incubation in supplemented
DMEM, muscles were rinsed in Krebs–Henseleit buffer
(KHB) supplemented with 0.1% BSA, 2 mm sodium
pyruvate, and 5 mmmannitol for sequential 20 min and
10 min periods at 30 C to rinse away glucose and
DMEM. During the rinse steps, the KHB was supple-
mented with 0, 0.6, or 12 nm insulin. Muscles treated
with PUGNAc in the initial incubation steps continued
to be exposed to 100 lm PUGNAc during the subse-
quent rinse steps. Overall the PUGNAc-treated muscles
were exposed to PUGNAc for a total duration of 8.5 h
prior to incubation with 3-O-methyl-d-glucose.
Finally, muscles were incubated at 30 C for 15 min
in 1.5 mL KHB containing 8 mM 3-O-methyl-d-glu-
cose ([3H]-3-MG; 0.5 mCi mmol)1) and 2 mm mann-
itol ([14C]-0.2 mCi mmol)1). Insulin concentrations
remained the same as in the preceding rinse steps (0,
0.6 or 12 nm insulin). Muscles were then rapidly
blotted, trimmed, clamp frozen with aluminium tongs
cooled to the temperature of liquid N2, and stored at
)80 C until further processing.
Muscle preparation
Frozen muscles were weighed, transferred to pre-chilled
glass tissue grinding tubes (Kontes) and homogenized in
ice-cold lysis buffer (1 mL muscle)1) containing 20 mm
Tris-HCl, pH 7.4, 150 mm NaCl, 1% NP-40 (v/v),
2 mm EDTA, 2 mm EGTA, 1 mm dithiothreitol,
2.5 mm sodium pyrophosphate, 10 mm sodium fluor-
ide, 2 mm sodium vanadate, 20 mm b-glycerophos-
phate, 2 lm PUGNAc, 1 lg mL)1 leupeptin, 1 lg mL)1
pepstatin, 1 lg mL)1 aprotinin, and 2 mm phenyl-
methylsulfonyl fluoride. Homogenates were transferred
to microfuge tubes, rotated for 1–2 h at 4 C and then
centrifuged at 12 000 · g for 15 min to remove insol-
uble material. Following homogenization, plantaris
 2005 Scandinavian Physiological Society 283
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muscle and liver samples from the calorie restriction
experiment were processed for Western blotting while
epitrochlearis muscle samples from the PUGNAc-incu-
bation experiment were used for determination of
glucose transport as well as for Western blotting.
Supernatants were transferred to fresh microfuge tubes
and duplicate 200 lL aliquots derived from epitrochle-
aris muscles were immediately used for scintillation
counting. [3H]-3-MG uptake was determined as previ-
ously described (Davidson et al. 2002). Protein concen-
trations of all supernatants were determined by the BCA
method (Smith et al. 1985).
Immunoblotting
Aliquots of supernatants were solubilized in SDS sample
buffer, boiled for 3 min and subjected to 8–10% SDS-
PAGE. Resolved proteins were transferred to nitrocel-
lulose paper overnight at a constant current of 150 mA/
transfer apparatus in electrotransfer buffer (20 mm
Tris, pH 8.0, 150 mm glycine, 0.025% SDS, 20%
methanol). Nitrocellulose blots were blocked in TBST-
HT (0.3% Tween-20 in tris-buffered saline, pH 7.5) for
1 h at room temperature and transferred to fresh TBST-
HT with either the CTD110.6 or RL2 anti-O-linked
N-acetylglucosamine antisera (1 : 1000) for 2 h at
room temperature or overnight at 4 C. Blots were then
washed and incubated in secondary antibody (goat anti-
mouse IgM-HRP, CTD110.6; anti-mouse IgG-HRP,
RL2; 1 : 5000) for 1 h at room temperature. Blots were
washed of excess antibody, subjected to enhanced
chemiluminescence, and immunoreactive protein was
quantified by densitometry.
Statistical analysis
All data are expressed as mean  SE. Differences
between groups (AL vs. CR) for the calorie restriction
experiment were evaluated by t-test. Differences be-
tween groups for the PUGNAc experiment (PUGNAc
vs. no PUGNAc) were evaluated by paired t-test.
Statistics were performed using SigmaSTAT (SPSS,
Chicago, IL, USA). P £ 0.05 was considered statistically
significant.
Results
O-linked glycosylation status of proteins from the
plantaris muscle from experiment 1 (the calorie restric-
tion study) was evaluated by Western blotting using
two different monoclonal antibodies, CTD110.6 and
RL2 (Fig. 1a). Multiple protein bands were detected by
CTD110.6 and RL2 antibodies and subsequently were
quantitated by densitometry (Fig. 1b and c). No
significant differences were found between CR and
AL in any of the detected protein bands using either
antibody.
In addition, we assessed the O-GlcNAcylation status
of the liver of experiment 1 (CR and AL) using the
CTD110.6 antibody (Fig. 2a). Multiple protein bands
were identified but no differences in O-GlcNAcylation
were observed between the CR and AL groups (Fig. 2b).
For experiment 2, incubation of epitrochlearis mus-
cles with 100 lm PUGNAc for 8.5 h resulted in
multiple protein bands demonstrating significantly
increased immunoreactivity against the CTD110.6
antibody compared with paired muscles incubated
without PUGNAc (Fig. 3a and b). As expected, glucose
transport increased with increasing insulin concentra-
tions. However, incubation with PUGNAc for 8.5 h did
not affect glucose transport with any insulin concentra-
tion (Fig. 4).
Discussion
The most important findings from this study were, (1)
CR did not cause a detectable difference between CR
and AL rats for protein O-GlcNAcylation of insulin-
responsive tissues, skeletal muscle and liver; and (2)
PUGNAc-induced O-GlcNAcylation of skeletal muscle
proteins preceded the development of insulin resist-
ance.
Increased skeletal muscle insulin sensitivity is a
hallmark of a moderate reduction in calorie consump-
tion, having been documented in vivo with the euglyce-
mic-hyperinsulinemic clamp of rats (Reaven et al.
1983), in perfused rat hindlimb (Ivy et al. 1991), and
in isolated muscle preparations from rats and mice
(Dean et al. 1998, Gazdag et al. 1999, Dean & Cartee
2000, McCurdy et al. 2003). The effect is found
rapidly, after only 20 days, in skeletal muscles of
various fibre type composition, including the predom-
inantly type I soleus (Gazdag et al. 1999), predomin-
antly type II-a flexor digitorum brevis (Gazdag et al.
1998), and predominantly type II-b epitrochlearis (Dean
et al. 1998, Gazdag et al. 1999, Dean & Cartee 2000,
McCurdy et al. 2003). Using the same CR protocol as
in experiment 1, we previously found increased insulin
sensitivity in the epitrochlearis concomitant with
reduced hexosamine levels in the plantaris muscle
(Gazdag et al. 2000).
The endproducts of the HBP are UDP-N-acetyl-
sugars which act as substrates for various transferases,
including OGT. OGT activity is believed to be princi-
pally regulated by cellular hexosamine concentrations
(Kreppel & Hart 1999), although it is also susceptible
to post-translational modifications which may alter its
activity (Kreppel et al. 1997). Increasing the flux
through the HBP results in increased levels of UDP-
sugar substrates and ultimately O-GlcNAcylation of
284  2005 Scandinavian Physiological Society
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Figure 1 O-linked glycosylation of skeletal muscle proteins from 20 day CR and AL rats. (a) Homogenates were subjected to
8% SDS-PAGE. Protein blots were probed with anti-O-GlcNAc (CTD110.6 and RL2) and visualized following ECL. Relative
molecular weight standards are denoted. Protein bands were quantitated by densitometry and values from CR-treated animals are
expressed relative to the mean value for the corresponding protein band in muscles from AL rats (mean  SE; n ¼ 7 for AL, n ¼ 9
for CR) for (b) CTD110.6, and (c) RL2.
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cellular proteins (Vosseller et al. 2002, Walgren et al.
2003).
In this context, the primary aim of this study was to
examine whether the previously described CR-induced
decrease in cellular hexosamines (Gazdag et al. 2000)
was accompanied by an alteration in the protein O-
GlcNAcylation status in rat skeletal muscle.
We used two antibodies, CTD110.6 and RL2, which
have been widely employed to detect O-linked glycosy-
lation in cells and tissues (Patti et al. 1999, Vosseller
et al. 2002, Walgren et al. 2003, Arias et al. 2004).
Specifically, CTD110.6, which was generated against a
synthetic glycopeptide with b-d-N-acetylglucosamine
on an internal serine residue, recognizes O-GlcNAc
with a beta-O-glycosidic linkage on both serine and
threonine. In contrast, RL2 was generated against
several O-GlcNAcylated proteins derived from the
nuclear pore complex-lamina fraction of rat liver
nuclear envelopes. Using these two antibodies, we were
able to detect multiple protein bands. Several of the
protein bands in skeletal muscle lysates were immuno-
reactive with both of the antibodies, suggesting the two
antibodies may have recognized some of the same
proteins. However, we were unable to detect differences
in protein O-GlcNAcylation between skeletal muscles
from CR compared with AL rats using either anti-
body. We also found no effect of CR on levels of
O-GlcNAcylated proteins in liver.
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Figure 2 O-linked glycosylation of liver proteins from 20 day CR and AL rats. (a) Homogenates were subjected to 8% SDS-PAGE.
Protein blots were probed with CTD110.6 and visualized following ECL. Relative molecular weight standards are denoted. (b)
Protein bands were quantitated by densitometry and values from CR-treated animals are expressed relative to the mean value for the
corresponding protein band in muscles from AL rats (mean  SE; n ¼ 8 for AL, n ¼ 8 for CR).
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Based on the mechanism we originally hypothes-
ized might lead to a CR-related effect on protein
O-GlcNAcylation, i.e. as the result of CR-induced
reduction in UDP-GlcNAc, we would have predicted
a general decline in O-GlcNAc-modified proteins.
However, the current results argue against a robust,
global effect of CR on protein O-GlcNAcylation in
skeletal muscle. There are several possible interpreta-
tions for the lack of any detectable CR-induced
change in protein O-GlcNAcylation, including: (1)
brief CR did not affect protein O-GlcNAcylation in
skeletal muscle and liver, (2) CR affected O-GlcNA-
cylation of proteins with low abundance and, there-
fore, below the sensitivity of our assays; (3) CR
affected proteins with O-GlcNAc motifs that are not
recognized by the antibodies used; and/or (4) CR
alters the O-GlcNAcylation of non-protein molecules
(e.g. glycolipids). Other methods for detection of
O-GlcNAcylation that do not rely on these antibodies
(Roquemore et al. 1994) may be useful for subsequent
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Figure 3 O-linked glycosylation of muscle proteins following 8.5 h incubation of paired skeletal muscles with or without 100 lm
PUGNAc. (a) Muscle homogenates were subjected to 8% SDS-PAGE. Protein blots were probed with CTD110.6 and visualized
following ECL. Relative molecular weight standards are denoted. (b) Protein bands were quantitated by densitometry and values
for PUGNAc-treated samples are expressed relative to the mean value for the corresponding protein band in muscles incubated
without PUGNAc (mean  SE; n ¼ 6 per group). Inset displays densitometric values for several protein bands using a different y
axis scale for clarity. *Significant difference for paired muscles with PUGNAc vs. without PUGNAc (P < 0.05).
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research to distinguish among these possible explana-
tions.
Recent studies have demonstrated that insulin resist-
ance and increased protein O-GlycNAcylation can be
induced by prolonged (19 h) incubation of skeletal
muscle (Arias et al. 2004) and 3T3-L1 adipocytes
(Vosseller et al. 2002) with PUGNAc, a potent inhibitor
of O-GlcNAcase. In the current study, however,
although protein O-GlcNAcylation in skeletal muscle
was markedly increased by incubation with PUGNAc
for 8.5 h, this treatment did not alter basal or insulin-
stimulated glucose transport. Taken together with our
previous results (Arias et al. 2004), these findings have
important implications, because they indicate that a
substantial increased in protein O-GlcNAcylation can
precede PUGNAc-induced insulin resistance in skeletal
muscle. The explanation for the delay between in-
creased protein O-GlcNAcylation and induction of
insulin resistance is unknown. Perhaps prolonged incu-
bation with PUGNAc is required to achieve a sufficient
level of O-GlcNAcylation of the specific proteins that
lead to insulin resistance. Alternatively, prolonged
PUGNAc exposure may induce insulin resistance indi-
rectly through a relatively slow process, e.g. altered gene
expression and protein abundance. Finally, although we
believe this to be unlikely, it remains possible that
PUGNAc-induced insulin resistance was unrelated to
PUGNAc’s well-established effect on O-GlyNAcylation
of proteins. Further experiments will be needed to
evaluate the potential importance of these suggested
explanations.
In conclusion, we were unable to detect differences
between CR and AL tissues (skeletal muscle or liver)
for O-GlcNAcylation of proteins, although the UDP-
HexNAc levels in rat skeletal muscle are significantly
lower for CR compared with AL rats (Gazdag et al.
2000). Secondly, we found that the induction of
O-GlcNAcylation in skeletal muscle by exposure to
PUGNAc, a potent inhibitor of O-GlcNAcase, pre-
cedes PUGNAc’s effects on insulin sensitivity. Using an
in vivo experimental model (CR) that leads to
increased insulin sensitivity in skeletal muscle (David-
son et al. 2002), and an in vitro model (PUGNAc
incubation) that leads to insulin resistance in skeletal
muscle (Arias et al. 2004), we have dissociated the
effects on insulin action from immunologically detec-
ted changes in protein O-GlcNAcylation. These find-
ings argue that the effect of brief CR on insulin
sensitivity is unlikely to be the direct result of a
marked, global change in muscle levels of O-GlcNAc-
ylated proteins.
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